141 related articles for article (PubMed ID: 7504165)
1. A radioimmunoassay for the N-terminal propeptide of rat procollagen type III. Application to the study of the uptake of the N-terminal propeptide of procollagen type III in isolated perfused rat liver.
Brocks DG; Steinert C; Gerl M; Knolle J; Neubauer HP; Günzler V
Matrix; 1993 Sep; 13(5):381-7. PubMed ID: 7504165
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the N-terminal propeptide of human type III procollagen.
Niemelä O; Risteli L; Parkkinen J; Risteli J
Biochem J; 1985 Nov; 232(1):145-50. PubMed ID: 4084223
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassays for type III procollagen amino-terminal peptides in humans.
Niemelä O
Clin Chem; 1985 Aug; 31(8):1301-4. PubMed ID: 4017234
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.
Linkhart SG; Linkhart TA; Taylor AK; Wergedal JE; Bettica P; Baylink DJ
Clin Chem; 1993 Nov; 39(11 Pt 1):2254-8. PubMed ID: 8222218
[TBL] [Abstract][Full Text] [Related]
5. Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs.
Bentsen KD; Boesby S; Kirkegaard P; Hansen CP; Jensen SL; Hørslev-Petersen K; Lorenzen I
J Hepatol; 1988 Apr; 6(2):144-50. PubMed ID: 3045193
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Clin Chim Acta; 1982 Sep; 124(1):39-44. PubMed ID: 7127838
[TBL] [Abstract][Full Text] [Related]
7. Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.
Han B; Copeland M; Geiser AG; Hale LV; Harvey A; Ma YL; Powers CS; Sato M; You J; Hale JE
J Proteome Res; 2007 Nov; 6(11):4218-29. PubMed ID: 17924680
[TBL] [Abstract][Full Text] [Related]
8. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
Risteli J; Niemi S; Trivedi P; Mäentausta O; Mowat AP; Risteli L
Clin Chem; 1988 Apr; 34(4):715-8. PubMed ID: 3359606
[TBL] [Abstract][Full Text] [Related]
9. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
10. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
Jensen LT
Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of type III procollagen N-terminal peptides in BAL fluid from normal and fibrotic lungs.
Harrison NK; McAnulty RJ; Kimpton WG; Fraser JR; Laurent TC; Laurent GJ
Eur Respir J; 1993 Nov; 6(10):1443-8. PubMed ID: 8112436
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescent localization of type III collagen and the N-terminal propeptide of type III procollagen in dentin matrix in osteogenesis imperfecta.
Lukinmaa PL
J Craniofac Genet Dev Biol; 1988; 8(3):235-43. PubMed ID: 3062037
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.
Melkko J; Niemi S; Risteli L; Risteli J
Clin Chem; 1990 Jul; 36(7):1328-32. PubMed ID: 2372946
[TBL] [Abstract][Full Text] [Related]
14. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells.
Smedsrød B
Coll Relat Res; 1988 Jul; 8(4):375-88. PubMed ID: 3215008
[TBL] [Abstract][Full Text] [Related]
15. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
[TBL] [Abstract][Full Text] [Related]
16. Development of a heterologous radioimmunoassay for canine osteocalcin.
Wang SP; Demarest KT; Gunnet JW; Baylink DJ; Lau KH
Calcif Tissue Int; 1994 Aug; 55(2):134-40. PubMed ID: 7953979
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease.
Schuppan D; Besser M; Schwarting R; Hahn EG
J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378
[TBL] [Abstract][Full Text] [Related]
18. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112
[TBL] [Abstract][Full Text] [Related]
19. Detection of procollagen biosynthesis using peptide-specific antibodies.
Mintz KP; Mann KG
Matrix; 1990 Jul; 10(3):186-99. PubMed ID: 1699117
[TBL] [Abstract][Full Text] [Related]
20. Immunoassay for intact amino-terminal propeptide of human type I procollagen.
Melkko J; Kauppila S; Niemi S; Risteli L; Haukipuro K; Jukkola A; Risteli J
Clin Chem; 1996 Jun; 42(6 Pt 1):947-54. PubMed ID: 8665688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
